Evidence map›Paper›PMID 27688770›Full record

ArticleInternational journal of analytical chemistry2016

A High-Throughput Size Exclusion Chromatography Method to Determine the Molecular Size Distribution of Meningococcal Polysaccharide Vaccine.

Imran Khan, K M Taufiqur Rahman, S M Saad Us Siraj, Mahbubul Karim, Abdul Muktadir, Arpan Maheshwari, Md Azizul Kabir, Zebun Nahar, Mohammad Mainul Ahasan

Open access · goldAbstract read
In one paragraph

Article in International journal of analytical chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Imran KhanIncepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh.
K M Taufiqur RahmanIncepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh.
S M Saad Us SirajIncepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh.
Mahbubul KarimIncepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh.
Abdul MuktadirIncepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh.
Arpan MaheshwariIncepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh.
Md Azizul KabirIncepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh.
Zebun NaharIncepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh.
Mohammad Mainul AhasanIncepta Vaccine Ltd., Zirabo, Savar, Dhaka 1341, Bangladesh.ORCID 0000-0002-8268-2206

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular size distribution of meningococcal polysaccharide vaccine is a readily identifiable parameter that directly correlates with the immunogenicity. In this paper, we report a size exclusion chromatography method to determine the molecular size distribution and distribution coefficient value of meningococcal polysaccharide serogroups A, C, W, and Y in meningococcal polysaccharide (ACWY) vaccines. The analyses were performed on a XK16/70 column packed with sepharose CL-4B with six different batches of Ingovax® ACWY, a meningococcal polysaccharide vaccine produced by Incepta Vaccine Ltd., Bangladesh. A quantitative rocket immunoelectrophoresis assay was employed to determine the polysaccharide contents of each serogroup. The calculated distribution coefficient values of serogroups A, C, W, and Y were found to be 0.26 ± 0.16, 0.21 ± 0.11, 0.21 ± 0.11, and 0.14 ± 0.12, respectively, and met the requirements of British Pharmacopeia. The method was proved to be robust for determining the distribution coefficient values which is an obligatory requirement for vaccine lot release.

Identifiers

PMID27688770
PMCPMC5027369
OpenAlexW2512626234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.